RxDoctor Payments Data

James Potter, DO

Anesthesiology · Roosevelt, UTNPI 1477942159

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Nevro Corp. at 25.1% of the total. Among anesthesiology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,952in general payments, 2019–2025

Across 77 payments — averaging $77.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$1K
  • Boston Scientific$1K
  • Medtronic$1K
  • Stryker$960
  • Globus Medical$366
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$81
  • plus $429 from 10 others

What the payments were for

  • Speaking & faculty fees$1,18620%
  • Travel & lodging$3,04351%
  • Food & beverage$1,72229%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,952 in reported general payments places this provider in the 95th percentile of 510 anesthesiology providers in Utah.

See all anesthesiology providers in Utah

Medicare billing

Part B allowed, 2024
$66,760
Medicare patients
122
Services billed
827

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen203$5,887
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen178$4,642
Oxycodone Hcl126$2,395
Pregabalin115$1,766
Gabapentin107$1,429
Morphine Sulfate ErMorphine Sulfate49$1,170
Butorphanol Tartrate18$891
Buprenorphine Hcl20$555
Diclofenac Sodium22$524
Methocarbamol15$449
Tramadol Hcl55$349
Celecoxib17$297
Cyclobenzaprine Hcl34$272
Methylprednisolone20$172
Duloxetine Hcl12$149

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Roosevelt

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →